CY1800A - Piroxicam solutions of increased stability without tissue-damaging effect - Google Patents

Piroxicam solutions of increased stability without tissue-damaging effect Download PDF

Info

Publication number
CY1800A
CY1800A CY180095A CY180095A CY1800A CY 1800 A CY1800 A CY 1800A CY 180095 A CY180095 A CY 180095A CY 180095 A CY180095 A CY 180095A CY 1800 A CY1800 A CY 1800A
Authority
CY
Cyprus
Prior art keywords
solution
pyroxycam
mass
tissue
damaging effect
Prior art date
Application number
CY180095A
Other languages
English (en)
Original Assignee
Egyt Gyogyszervegyeszeti Gyar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Egyt Gyogyszervegyeszeti Gyar filed Critical Egyt Gyogyszervegyeszeti Gyar
Publication of CY1800A publication Critical patent/CY1800A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
CY180095A 1990-11-27 1995-02-17 Piroxicam solutions of increased stability without tissue-damaging effect CY1800A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU907654A HU205550B (en) 1990-11-27 1990-11-27 Process for producing pyroxycam solution of increased stability, free from effects damaging tussues

Publications (1)

Publication Number Publication Date
CY1800A true CY1800A (en) 1995-02-17

Family

ID=10972319

Family Applications (1)

Application Number Title Priority Date Filing Date
CY180095A CY1800A (en) 1990-11-27 1995-02-17 Piroxicam solutions of increased stability without tissue-damaging effect

Country Status (13)

Country Link
US (1) US5169847A (cs)
JP (1) JPH04275222A (cs)
AT (1) AT397462B (cs)
CY (1) CY1800A (cs)
CZ (1) CZ281142B6 (cs)
DE (1) DE4139017C2 (cs)
GB (1) GB2250197B (cs)
HU (1) HU205550B (cs)
IT (1) IT1261955B (cs)
MY (1) MY108601A (cs)
RO (1) RO113303B1 (cs)
RU (1) RU2062616C1 (cs)
SK (1) SK278929B6 (cs)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6465016B2 (en) 1996-08-22 2002-10-15 Research Triangle Pharmaceuticals Cyclosporiine particles
US6979456B1 (en) 1998-04-01 2005-12-27 Jagotec Ag Anticancer compositions
IL139779A (en) 1998-05-29 2007-06-17 Rtp Pharma Inc Heat-protected microparticle preparations and a process for their final sterilization in steam
US7097849B2 (en) 1998-08-19 2006-08-29 Jagotec Ag Injectable aqueous dispersions of propofol
EE05190B1 (et) 1998-11-20 2009-08-17 Rtp Pharma Inc. Dispergeeruvad fosfolipiididega stabiliseeritud mikroosakesed
RU2161955C1 (ru) * 1999-07-16 2001-01-20 Эпштейн Олег Ильич Способ изменения физико-химических или физико-химических и биологических свойств вещества
DE10030345A1 (de) * 2000-06-20 2002-01-10 Boehringer Ingelheim Vetmed Hochkonzentrierte stabile Meloxicamlösungen
US20020035107A1 (en) * 2000-06-20 2002-03-21 Stefan Henke Highly concentrated stable meloxicam solutions
US8586094B2 (en) 2000-09-20 2013-11-19 Jagotec Ag Coated tablets
DE10161077A1 (de) 2001-12-12 2003-06-18 Boehringer Ingelheim Vetmed Hochkonzentrierte stabile Meloxicamlösungen zur nadellosen Injektion
US8992980B2 (en) 2002-10-25 2015-03-31 Boehringer Ingelheim Vetmedica Gmbh Water-soluble meloxicam granules
GB2404336A (en) * 2003-07-30 2005-02-02 Cipla Ltd Stabilisation of therapeutic agents using a carbonate salt of an amino acid, preferably in the presence of a saccharide, & pharmaceutical compositions thereof
EP1568369A1 (en) * 2004-02-23 2005-08-31 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the treatment of respiratory diseases in pigs
DE102004021281A1 (de) * 2004-04-29 2005-11-24 Boehringer Ingelheim Vetmedica Gmbh Verwendung von Meloxicam-Formulierungen in der Veterinärmedizin
DE102004030409A1 (de) * 2004-06-23 2006-01-26 Boehringer Ingelheim Vetmedica Gmbh Neue Verwendung von Meloxicam in der Veterinärmedizin
SG166115A1 (en) * 2005-09-30 2010-11-29 Boehringer Ingelheim Vetmed Pharmaceutical preparation containing meloxicam
JP5559339B2 (ja) * 2009-10-12 2014-07-23 ベーリンガー インゲルハイム フェトメディカ ゲゼルシャフト ミット ベシュレンクテル ハフツング メロキシカムを含む組成物のための容器
US9149480B2 (en) 2010-03-03 2015-10-06 Boehringer Ingeleheim Vetmedica GmbH Use of meloxicam for the long-term treatment of musculoskeletal disorders in cats
US20110218191A1 (en) * 2010-03-03 2011-09-08 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the long term-treatment of kidney disorders in cats
US9795568B2 (en) 2010-05-05 2017-10-24 Boehringer Ingelheim Vetmedica Gmbh Low concentration meloxicam tablets

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3217315C2 (de) * 1982-05-08 1986-05-22 Gödecke AG, 1000 Berlin Arzneimittelzubereitungen mit einem Gehalt an Oxicam-Derivaten
IT1216686B (it) * 1988-04-01 1990-03-08 Chiesi Farma Spa Formulazioni farmaceutiche acquose di piroxicam e procedimento per laloro preparazione.

Also Published As

Publication number Publication date
MY108601A (en) 1996-10-31
HU907654D0 (en) 1991-06-28
CZ281142B6 (cs) 1996-06-12
ATA236791A (de) 1993-09-15
DE4139017C2 (de) 2000-04-27
GB9125268D0 (en) 1992-01-29
CS360091A3 (en) 1992-06-17
GB2250197A (en) 1992-06-03
DE4139017A1 (de) 1992-06-04
US5169847A (en) 1992-12-08
AT397462B (de) 1994-04-25
GB2250197B (en) 1994-06-22
RO113303B1 (ro) 1998-06-30
JPH04275222A (ja) 1992-09-30
RU2062616C1 (ru) 1996-06-27
IT1261955B (it) 1996-06-11
ITMI913171A0 (it) 1991-11-27
SK278929B6 (sk) 1998-04-08
ITMI913171A1 (it) 1993-05-27
HU205550B (en) 1992-05-28

Similar Documents

Publication Publication Date Title
US5169847A (en) Drug solutions of increased stability and without tissue-damaging effect and process for preparing same
KR920003332B1 (ko) 에토포시드(Etoposide)제제의 제조방법
CA1251734A (en) Stabilized injectable solutions of piroxicam
US5589491A (en) Injection and injection kit containing omeprazole and its analogs
EP0472327B1 (en) Composition for eye drops
DE69019774T2 (de) Isochinolin-Derivate zur Behandlung des Glaukoms oder der okulären Hypertonie.
KR20000068528A (ko) 4,5-에폭시모르피난 유도체를 함유하는 안정한 의약품 조성물
NO172674B (no) Fremgangsmaate for fremstilling av basiske, vandige preparater av karboksylsyrer
JP3835815B2 (ja) エンロフロキサシンの注射用もしくは注入用溶液
EP0604570B1 (en) Compositions containing quinolone antibiotics and sulfonate of polystyrol
EP0233615B1 (en) Aqueous preparation and method of preparation thereof
IL103270A (en) Sparfloxacin solution and its preparation
US4518606A (en) Pharmaceutical compositions
JP2536173B2 (ja) 注射剤
HU211580A9 (hu) Megnövelt stabilitású, szövetkárosító hatás nélküli piroxikam-oldatok Az átmeneti oltalom az 1., 2., 5. és 6. igénypontokra vonatkozik.
EP0508311B1 (en) Injectable compositions containing 2-oxindole-1-carboxamide derivatives
GB1564454A (en) Antiglaucomatous ophtalmic solution
EP0640074B1 (en) Salts of a quinolone-carboxylic acid
JP2822049B2 (ja) 水性製剤組成物
JPH0366617A (ja) 静脈内投与用フエニトインナトリウム製剤
CA2142445C (en) Injection solutions of azosemide which are ready for injection
JPH03106816A (ja) 緑内障治療用点眼剤
KR900002745B1 (ko) 안정 주사용 진토제 조성물의 제조방법
US5252583A (en) Isoquinoline derivatives for the treatment of glaucoma or ocular hypertension
KR0178308B1 (ko) 수용액